Kalbe Farma (Indonesia) provided earnings guidance for the full year 2015. The company expected its full-year 2015 sales to grow 2%-3% year on year and its net profit to fall by 3%-4% year on year, amid slowing macroeconomic conditions.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,540 IDR | +1.32% | -0.65% | -4.35% |
05-17 | Nomura Adjusts Kalbe Farma’s Price Target to 1,900 Rupiahs From 1,850 Rupiahs, Keeps at Buy | MT |
04-30 | PT Kalbe Farma Tbk. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.35% | 4.39B | |
+42.83% | 750B | |
+34.11% | 606B | |
-5.70% | 356B | |
+18.06% | 326B | |
+4.63% | 286B | |
+18.30% | 246B | |
-2.78% | 213B | |
+11.24% | 213B | |
+2.43% | 167B |
- Stock Market
- Equities
- KLBF Stock
- News PT Kalbe Farma Tbk.
- Kalbe Farma Provides Earnings Guidance for the Full Year 2015